A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to CLL/SLL
Related studies linked through entity extraction aliases.
Global Trial in APG2575 for Patients With CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE3
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1